• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复制研究:感染在人结直肠癌细胞中普遍存在。

Replication Study: infection is prevalent in human colorectal carcinoma.

机构信息

ARQ Genetics, Bastrop, United States.

出版信息

Elife. 2018 Mar 13;7:e25801. doi: 10.7554/eLife.25801.

DOI:10.7554/eLife.25801
PMID:29533182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5849410/
Abstract

As part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Repass et al., 2016), that described how we intended to replicate an experiment from the paper ' infection is prevalent in human colorectal carcinoma' (Castellarin et al., 2012). Here we report the results. When measuring DNA by qPCR in colorectal carcinoma (CRC), adjacent normal tissue, and separate matched control tissue, we did not detect a signal for in most samples: 25% of CRCs, 15% of adjacent normal, and 0% of matched control tissue were positive based on quantitative PCR (qPCR) and confirmed by sequencing of the qPCR products. When only samples with detectable in CRC and adjacent normal tissue were compared, the difference was not statistically significant, while the original study reported a statistically significant increase in expression in CRC compared to adjacent normal tissue (Figure 2; Castellarin et al., 2012). Finally, we report a meta-analysis of the result, which suggests expression is increased in CRC, but is confounded by the inability to detect in most samples. The difference in expression between CRC and adjacent normal tissues was thus smaller than the original study, and not detected in most samples.

摘要

作为《癌症生物学可重复性计划》的一部分,我们发表了一份注册报告(Repass 等人,2016 年),描述了我们打算如何复制 Castellarin 等人(2012 年)论文中“感染在人类结直肠癌中普遍存在”的实验。现将结果报告如下。在通过 qPCR 测量结直肠癌(CRC)、相邻正常组织和单独匹配对照组织中的 DNA 时,我们没有在大多数样本中检测到的信号:根据定量 PCR(qPCR),CRC 中有 25%、相邻正常组织中有 15%、匹配对照组织中有 0%的样本呈阳性,并且通过 qPCR 产物的测序得到了证实。当仅比较 CRC 和相邻正常组织中可检测到的样本时,差异没有统计学意义,而原始研究报告称 CRC 中表达增加具有统计学意义与相邻正常组织相比(图 2;Castellarin 等人,2012 年)。最后,我们报告了该结果的荟萃分析,表明在 CRC 中表达增加,但由于大多数样本无法检测到,因此存在混淆。CRC 和相邻正常组织之间的表达差异因此小于原始研究,并且在大多数样本中未检测到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/fd7ab3c90091/elife-25801-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/5e0352acc0df/elife-25801-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/2d82ecaf6576/elife-25801-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/d97f2eaad4f6/elife-25801-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/39b51e99b5bc/elife-25801-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/3af365c2cd7d/elife-25801-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/fd7ab3c90091/elife-25801-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/5e0352acc0df/elife-25801-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/2d82ecaf6576/elife-25801-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/d97f2eaad4f6/elife-25801-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/39b51e99b5bc/elife-25801-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/3af365c2cd7d/elife-25801-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/981c/5849410/fd7ab3c90091/elife-25801-fig3.jpg

相似文献

1
Replication Study: infection is prevalent in human colorectal carcinoma.复制研究:感染在人结直肠癌细胞中普遍存在。
Elife. 2018 Mar 13;7:e25801. doi: 10.7554/eLife.25801.
2
Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.注册报告:具核梭杆菌感染在人类结直肠癌中普遍存在。
Elife. 2016 Feb 11;5:e10012. doi: 10.7554/eLife.10012.
3
Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.具核梭杆菌与通路突变及其与结直肠癌患者预后的关联
Ann Surg Oncol. 2018 Oct;25(11):3389-3395. doi: 10.1245/s10434-018-6681-5. Epub 2018 Jul 30.
4
Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.具核梭杆菌作为日本人群结直肠癌的预后标志物。
J Gastroenterol. 2018 Apr;53(4):517-524. doi: 10.1007/s00535-017-1382-6. Epub 2017 Aug 19.
5
Relationship between , inflammatory mediators and microRNAs in colorectal carcinogenesis.在结直肠癌发生过程中 、炎症介质和 microRNAs 之间的关系。
World J Gastroenterol. 2018 Dec 21;24(47):5351-5365. doi: 10.3748/wjg.v24.i47.5351.
6
Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.具核梭杆菌通过 E-钙黏蛋白/β-连环蛋白/谷胱甘肽过氧化物酶 4 轴抑制铁死亡诱导结直肠癌细胞对奥沙利铂耐药。
Free Radic Biol Med. 2024 Aug 1;220:125-138. doi: 10.1016/j.freeradbiomed.2024.04.226. Epub 2024 Apr 22.
7
Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.具核梭杆菌感染的人结直肠癌细胞中 microRNA-4474/4717 表达和 CREB 结合蛋白的改变。
PLoS One. 2019 Apr 5;14(4):e0215088. doi: 10.1371/journal.pone.0215088. eCollection 2019.
8
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.具核梭杆菌与结直肠锯齿状途径中临床及分子特征的关联
Int J Cancer. 2015 Sep 15;137(6):1258-68. doi: 10.1002/ijc.29488. Epub 2015 Mar 13.
9
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.具核梭杆菌通过激活Toll样受体4信号传导至核因子κB并上调微小RNA-21的表达来增加结肠直肠癌细胞的增殖和小鼠肿瘤的发展。
Gastroenterology. 2017 Mar;152(4):851-866.e24. doi: 10.1053/j.gastro.2016.11.018. Epub 2016 Nov 19.
10
's link to colorectal neoplasia sequenced: A systematic review and future insights.'s 与结直肠肿瘤发生的关联:系统评价及未来展望。
World J Gastroenterol. 2017 Dec 28;23(48):8626-8650. doi: 10.3748/wjg.v23.i48.8626.

引用本文的文献

1
Association of with colorectal cancer molecular subtypes and its outcome: a systematic review.[具体因素]与结直肠癌分子亚型的关联及其预后:一项系统综述。 (这里原文中“Association of with”缺少具体内容,翻译时添加了“[具体因素]”来使句子完整)
Gut Microbiome (Camb). 2025 Apr 8;6:e5. doi: 10.1017/gmb.2025.3. eCollection 2025.
2
A Prebiotic Diet Containing Galactooligosaccharides and Polydextrose Produces Dynamic and Reproducible Changes in the Gut Microbial Ecosystem in Male Rats.一种含有半乳糖低聚糖和聚右旋糖的益生元饮食可在雄性大鼠的肠道微生物生态系统中产生动态且可重现的变化。
Nutrients. 2024 Jun 6;16(11):1790. doi: 10.3390/nu16111790.
3
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.

本文引用的文献

1
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas.癌旁乳腺组织中的DNA缺陷、表观遗传学与基因表达:来自癌症基因组图谱的一项研究
NPJ Breast Cancer. 2016 May 4;2:16007. doi: 10.1038/npjbcancer.2016.7. eCollection 2016.
2
Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.饮食模式与肿瘤组织中具核梭杆菌分类的结直肠癌亚型风险的关联。
JAMA Oncol. 2017 Jul 1;3(7):921-927. doi: 10.1001/jamaoncol.2016.6374.
3
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.
一种新兴策略:益生菌通过调节肠道微生物组来增强肿瘤免疫疗法的效果。
Gut Microbes. 2024 Jan-Dec;16(1):2341717. doi: 10.1080/19490976.2024.2341717. Epub 2024 May 8.
4
Intratumoural microbiota: a new frontier in cancer development and therapy.肿瘤内微生物群:癌症发展和治疗的新前沿。
Signal Transduct Target Ther. 2024 Jan 10;9(1):15. doi: 10.1038/s41392-023-01693-0.
5
promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation.通过 ADP-庚糖的释放和 ALPK1/TIFA 轴的激活,促进结直肠癌细胞的炎症和抗凋亡反应。
Gut Microbes. 2024 Jan-Dec;16(1):2295384. doi: 10.1080/19490976.2023.2295384. Epub 2023 Dec 21.
6
Biosensors for point-of-care testing and personalized monitoring of gastrointestinal microbiota.用于即时检测和胃肠道微生物群个性化监测的生物传感器。
Front Microbiol. 2023 May 5;14:1114707. doi: 10.3389/fmicb.2023.1114707. eCollection 2023.
7
A randomized, double-blinded study evaluating effect of matcha green tea on human fecal microbiota.一项评估抹茶绿茶对人体粪便微生物群影响的随机双盲研究。
J Clin Biochem Nutr. 2023 Mar;72(2):165-170. doi: 10.3164/jcbn.22-81. Epub 2022 Nov 23.
8
Microbiota-Liver Diseases Interactions.微生物群-肝脏疾病相互作用。
Int J Mol Sci. 2023 Feb 15;24(4):3883. doi: 10.3390/ijms24043883.
9
Microbial Metabolite Dysbiosis and Colorectal Cancer.微生物代谢物失调与结直肠癌
Gut Liver. 2023 Mar 15;17(2):190-203. doi: 10.5009/gnl220260. Epub 2023 Jan 12.
10
Evaluating the predictive performance of gut microbiota for the early-stage colorectal cancer.评估肠道微生物群对早期结直肠癌的预测性能。
BMC Gastroenterol. 2022 Dec 12;22(1):514. doi: 10.1186/s12876-022-02599-x.
根据肿瘤位置分析结直肠癌组织中的具核梭杆菌
Clin Transl Gastroenterol. 2016 Nov 3;7(11):e200. doi: 10.1038/ctg.2016.53.
4
Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.抗具核梭杆菌抗体水平在结直肠癌血清学诊断中的评估
Sci Rep. 2016 Sep 28;6:33440. doi: 10.1038/srep33440.
5
Adapting Cancer Immunotherapy Models for the Real World.使癌症免疫治疗模型适应现实世界。
Trends Immunol. 2016 Jun;37(6):354-363. doi: 10.1016/j.it.2016.03.010. Epub 2016 Apr 19.
6
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.具核梭杆菌感染与中国患者结直肠癌的关联
World J Gastroenterol. 2016 Mar 21;22(11):3227-33. doi: 10.3748/wjg.v22.i11.3227.
7
Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.注册报告:具核梭杆菌感染在人类结直肠癌中普遍存在。
Elife. 2016 Feb 11;5:e10012. doi: 10.7554/eLife.10012.
8
Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.比较来自福尔马林固定、石蜡包埋组织和定量聚合酶链反应的基因表达数据与来自速冻组织和微阵列的基因表达数据,以对卵巢癌患者的预后进行建模。
BMC Clin Pathol. 2015 Sep 24;15:17. doi: 10.1186/s12907-015-0017-1. eCollection 2015.
9
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.结直肠癌组织中的具核梭杆菌与患者预后
Gut. 2016 Dec;65(12):1973-1980. doi: 10.1136/gutjnl-2015-310101. Epub 2015 Aug 26.
10
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.具核梭杆菌与结直肠癌中的 T 细胞
JAMA Oncol. 2015 Aug;1(5):653-61. doi: 10.1001/jamaoncol.2015.1377.